The contractor shall perform the following functions:
Act as a repository for the storage and distribution of biological
reagents and tumor cell lines, which are then made available to the
scientific community.
Assay microbiological agents to satisfy FDA requirements, in preparation
for clinical trials.
Conduct purification, modification, vialing, and testing of biologics
obtained in bulk form for clinical use.
Conduct general safety tests on biologics intended for clinical use.
Produce GLP-grade monoclonal antibodies for preclinical evaluation and
testing, as well as GMP-quality monoclonals.
No Sub Projects information available for N01CM017531-014
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for N01CM017531-014
Patents
No Patents information available for N01CM017531-014
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for N01CM017531-014
Clinical Studies
No Clinical Studies information available for N01CM017531-014
News and More
Related News Releases
No news release information available for N01CM017531-014
History
No Historical information available for N01CM017531-014
Similar Projects
No Similar Projects information available for N01CM017531-014